Operating income increased 65.0%
Operating income changed +65.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$4.6M→-$1.6M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SCWO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed across a sign change
Operating cash flow changed +105.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$4.1M→$210,9654 prior comparisons
Operating margin moved 70783 bp higher
Operating margin changed +70783 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-779.53%→-71.70%3 prior comparisons
Gross margin moved 13411 bp higher
Gross margin changed +13411 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-46.45%→87.66%3 prior comparisons
Revenue increased 280.2%
Revenue changed +280.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$594,967→$2.3M3 prior comparisons
Capital expenditure changed across a low base
Capital expenditure changed +5751.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$15,508→$907,4914 prior comparisons
Research & development decreased 46.4%
Research & development changed -46.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$531,170→$284,5893 prior comparisons
Inventory / revenue moved 23388 bp lower
Inventory / revenue changed -23388 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
306.20%→72.32%3 prior comparisons
Trade receivables decreased 27.8%
Trade receivables changed -27.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$863,819→$623,6634 prior comparisons
Capex / revenue moved 3751 bp higher
Capex / revenue changed +3751 basis points from the comparable as-filed period.
2.61%→40.12%3 prior comparisons
Working capital decreased 47.9%
Working capital changed -47.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$4.6M→$2.4M4 prior comparisons
Cost of revenue decreased 68.0%
Cost of revenue changed -68.0% from the comparable as-filed period.
$871,333→$279,0673 prior comparisons
Free-cash-flow margin moved 66540 bp higher
Free-cash-flow margin changed +66540 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-696.19%→-30.79%3 prior comparisons
Operating cash-flow margin moved 70291 bp higher
Operating cash-flow margin changed +70291 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-693.58%→9.33%3 prior comparisons
R&D / revenue moved 7670 bp lower
R&D / revenue changed -7670 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
89.28%→12.58%3 prior comparisons
Receivables / revenue moved 11762 bp lower
Receivables / revenue changed -11762 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
145.19%→27.57%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.